Ambroxol Induces Autophagy and Potentiates Rifampin Antimycobacterial Activity | Zendy

Seong Won Choi | Zendy; Yuexi Gu | Zendy; Ryan Peters | Zendy; Padmini Salgame | Zendy; Jerrold J. Ellner | Zendy; Graham S. Timmins | Zendy; Vojo Deretić | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ambroxol Induces Autophagy and Potentiates Rifampin Antimycobacterial Activity

Author(s) -

Seong Won Choi,

Yuexi Gu,

Ryan Peters,

Padmini Salgame,

Jerrold J. Ellner,

Graham S. Timmins,

Vojo Deretić

Publication year - 2018

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01019-18

Subject(s) - antimycobacterial , ambroxol , autophagy , mycobacterium tuberculosis , tuberculosis , antibiotics , antimicrobial , microbiology and biotechnology , pharmacology , mycobacterium avium complex , medicine , chemotherapy , biology , apoptosis , pathology , biochemistry , anesthesia

Host-directed therapy in tuberculosis is a potential adjunct to antibiotic chemotherapy directed atMycobacterium tuberculosis . Ambroxol, a lead compound, emerged from a screen for autophagy-inducing drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research